2.1 Heart failure is a complex clinical syndrome of symptoms and signs that happen when the heart is not working well enough, leading to reduced blood flow to body tissues. It can lead to oedema in ...

MINNEAPOLIS, MN—A novel implantable device that provides both cardiac contractility modulation as well as defibrillation (CCM-D) successfully and safely delivers integrated therapy, while also ...

Please provide your email address to receive an email when new articles are posted on . A novel implantable cardioverter defibrillator platform may benefit patients with HF not eligible for cardiac ...

Heart failure (HF) is a pervasive and growing health issue worldwide. It affects approximately 64 million people globally. The numbers are on the rise due to ageing populations and the increasing ...

The American Medical Association’s CPT editorial panel will meet May 1-3 to consider codes for several devices and services, but the most important of these might be the code for cardiac contractility ...

MINNEAPOLIS -- The novel dual-function cardiac contractility modulation-defibrillator (CCM-D) for heart failure with reduced ejection fraction (HFrEF) had favorable early results in the Integra-D ...

SIOUX CITY (KTIV) - Brad Hedlund has been in and out of appointments with cardiologists dealing with heart failure over the last decade. Hedlund explained his symptoms as “I had no energy. I had no ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

MYQORZO is indicated for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacity and symptoms. MYQORZO is contraindicated with ...

BUFFALO, N.Y. — It is considered groundbreaking technology in Buffalo when it comes to heart health. Cardiac Contractility Modulation Therapy (CCM) is a device that can be implanted in patients. There ...